Spleen and stomach deficiency
Conditions
Interventions
Experimental Group:Study participants will receive the investigational product for 28 days.
Sponsors
Zhejiang Provincial Tongde Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Age between 18 and 65 years (inclusive); (2) Individuals with spleen-stomach deficiency, such as loss of appetite, indigestion (gastric fullness, distension, or distension-related discomfort), abnormal bowel movements (loose stools or diarrhea), sallow complexion, and fatigue; with recurrent symptoms lasting for more than one month. (3) Ability to complete the 4-week clinical study per the study protocol. Consent to and signature on the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Individuals with cardiovascular, cerebrovascular, hepatic, renal, hematopoietic, irritable bowel syndrome, or inflammatory bowel syndrome disorders; (2) Women who are planning pregnancy, pregnant, lactating, or have known allergies; (3) Individuals with psychiatric disorders who cannot complete the rating scales; (4) Individuals who have taken or used drugs or health supplements related to the study within the past month, potentially affecting outcome assessment; (5) Individuals who have participated in other clinical trials within the past three months; Individuals deemed by the investigator to be unable to fully comply with the trial schedule.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM Syndrome Score Scale;PRO Scale for Spleen-Stomach Disorders;Three gastric function tests: Pepsinogen I, Pepsinogen II, and Gastrin-17; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vital Signs;Mental status, sleep, diet, and bowel/bladder function-main clinical symptoms; | — |
Countries
China
Contacts
Public ContactChen Mingxian
Zhejiang Provincial Tongde Hospital
Outcome results
None listed